Jefferies Group’s AngioDynamics ANGO Stock Holding History

Jefferies Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,111	Closed	-$207K	–	2470
2017 Q3	$207K	Buy	+12,111	New	+$203K	﹤0.01%	2063
2017 Q2	–	Sell	-10,434	Closed	-$181K	–	2154
2017 Q1	$181K	Buy	+10,434	New	+$174K	﹤0.01%	2046
2014 Q3	–	Sell	-45,523	Closed	-$743K	–	2124
2014 Q2	$743K	Sell	45,523 -13,531	-23%	-$196K	0.01%	1035
2014 Q1	$930K	Buy	+59,054	New	+$962K	0.01%	958

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Jefferies Group's ANGO Position: Q4 2017 in Review

Jefferies Group sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 12,111 shares — an estimated $207K sold.

Jefferies Group first reported a position in ANGO in Q1 2014 and held it in 4 quarters. The position peaked at $930K in Q1 2014. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.

Jefferies Group reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
Jefferies Group sold 12,111 AngioDynamics shares in Q4 2017, an estimated $207K.
Jefferies Group first reported a position in AngioDynamics in Q1 2014 and held it in 4 quarters.
Jefferies Group's AngioDynamics position peaked at $930K in Q1 2014.
169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.